Composition and method for reducing hypoglycemia events in diabetes treatment
US11110151B2 · kind B2 · utility
1Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2019 |
| Grant date | Sep 7, 2021 |
| Priority date | — |
| Expiry date | Jun 21, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/545
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An ultra-rapid acting insulin composition and method for treating hyperglycemia in patients with diabetes are disclose. The composition is an inhalable dry powder composition comprising fumaryl diketopiperazine and insulin for pulmonary delivery, which significantly reduces the rates of hypoglycemic events in patients in patients on mealtime insulin therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.